“The impressive growth is a result of quality products and assertive marketing strategies. Delius Pharmaceuticals is poised for significant market impact. We see a future where Delius not only dominates the Pharma Industry in India but also expands globally,” said Chief Sales Officer Sahil. “We are planning an initial public offering (IPO) within 2-3 years,” Sahil added.
Our mission extends beyond profit, aiming to establish more manufacturing units and provide employment opportunities for nearly 500 individuals.